Gedeon Richter - PregLem S.A.
Grégory Chevenier has extensive experience in the pharmaceutical industry, currently serving as Directeur du développement commercial and Directeur des Ventes at Gedeon Richter France since August 2012, focusing on women's health, gynecology, and reproductive medicine. In addition, Grégory holds the position of Sales Manager at Gedeon Richter - PregLem S.A. since the same date. Prior experience includes serving as Regional Sales Manager at Pierre Fabre Group from January 2005 to July 2010, where responsibilities spanned various therapeutic areas including gynecology and cardiology. Grégory Chevenier holds a DEUST in Sciences et technologies pharmaceutiques from Université De Lorraine - Faculté de Médecine, earned between 1999 and 2001.
This person is not in any offices
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.